consort healthcare (edinburgh royal infirmary) limited

Live MatureLargeDeclining

consort healthcare (edinburgh royal infirmary) limited Company Information

Share CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED

Company Number

SC187449

Directors

John Cavill

Glenn Pearce

View All

Shareholders

project & export finance (nominees) limited

Group Structure

View All

Industry

Construction of commercial buildings

 +2

Registered Address

c/o infrastructure managers limi, 2nd floor drum suite, saltire co, edinburgh, EH1 2EN

consort healthcare (edinburgh royal infirmary) limited Estimated Valuation

£11.4m

Pomanda estimates the enterprise value of CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED at £11.4m based on a Turnover of £23.5m and 0.49x industry multiple (adjusted for size and gross margin).

consort healthcare (edinburgh royal infirmary) limited Estimated Valuation

£17.3m

Pomanda estimates the enterprise value of CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED at £17.3m based on an EBITDA of £4m and a 4.33x industry multiple (adjusted for size and gross margin).

consort healthcare (edinburgh royal infirmary) limited Estimated Valuation

£160.9m

Pomanda estimates the enterprise value of CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED at £160.9m based on Net Assets of £83.5m and 1.93x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Consort Healthcare (edinburgh Royal Infirmary) Limited Overview

Consort Healthcare (edinburgh Royal Infirmary) Limited is a live company located in edinburgh, EH1 2EN with a Companies House number of SC187449. It operates in the construction of commercial buildings sector, SIC Code 41201. Founded in July 1998, it's largest shareholder is project & export finance (nominees) limited with a 100% stake. Consort Healthcare (edinburgh Royal Infirmary) Limited is a mature, large sized company, Pomanda has estimated its turnover at £23.5m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Consort Healthcare (edinburgh Royal Infirmary) Limited Health Check

Pomanda's financial health check has awarded Consort Healthcare (Edinburgh Royal Infirmary) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

4 Strong

positive_score

3 Regular

positive_score

3 Weak

size

Size

annual sales of £23.5m, make it larger than the average company (£8.4m)

£23.5m - Consort Healthcare (edinburgh Royal Infirmary) Limited

£8.4m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -3%, show it is growing at a slower rate (7.8%)

-3% - Consort Healthcare (edinburgh Royal Infirmary) Limited

7.8% - Industry AVG

production

Production

with a gross margin of 13.4%, this company has a higher cost of product (26.2%)

13.4% - Consort Healthcare (edinburgh Royal Infirmary) Limited

26.2% - Industry AVG

profitability

Profitability

an operating margin of 17.1% make it more profitable than the average company (5.4%)

17.1% - Consort Healthcare (edinburgh Royal Infirmary) Limited

5.4% - Industry AVG

employees

Employees

with 106 employees, this is above the industry average (31)

106 - Consort Healthcare (edinburgh Royal Infirmary) Limited

31 - Industry AVG

paystructure

Pay Structure

There is insufficient data available for this Key Performance Indicator!

- - Consort Healthcare (edinburgh Royal Infirmary) Limited

- - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £221.3k, this is equally as efficient (£245.2k)

£221.3k - Consort Healthcare (edinburgh Royal Infirmary) Limited

£245.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 164 days, this is later than average (48 days)

164 days - Consort Healthcare (edinburgh Royal Infirmary) Limited

48 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 55 days, this is slower than average (36 days)

55 days - Consort Healthcare (edinburgh Royal Infirmary) Limited

36 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Consort Healthcare (edinburgh Royal Infirmary) Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 23 weeks, this is average cash available to meet short term requirements (21 weeks)

23 weeks - Consort Healthcare (edinburgh Royal Infirmary) Limited

21 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 64.8%, this is a similar level of debt than the average (63.9%)

64.8% - Consort Healthcare (edinburgh Royal Infirmary) Limited

63.9% - Industry AVG

CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED financials

EXPORTms excel logo

Consort Healthcare (Edinburgh Royal Infirmary) Limited's latest turnover from December 2023 is £23.5 million and the company has net assets of £83.5 million. According to their latest financial statements, we estimate that Consort Healthcare (Edinburgh Royal Infirmary) Limited has 106 employees and maintains cash reserves of £52.9 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover23,462,45820,850,57523,061,35125,757,21924,702,16923,992,28924,477,92227,459,64027,074,11944,579,99435,275,00029,905,00031,457,00026,701,00022,386,000
Other Income Or Grants
Cost Of Sales20,322,92916,555,54414,833,17316,469,05016,441,13116,328,95816,329,94320,132,69219,616,73237,966,94929,532,00024,701,00025,759,00020,717,00018,264,000
Gross Profit3,139,5294,295,0318,228,1789,288,1698,261,0387,663,3318,147,9797,326,9487,457,3876,613,0455,743,0005,204,0005,698,0005,984,0004,122,000
Admin Expenses-864,2084,681,4071,532,6021,010,526781,792867,122567,598655,373793,130848,054886,0001,047,0001,148,0001,425,0001,149,000
Operating Profit4,003,737-386,3766,695,5768,277,6437,479,2466,796,2097,580,3816,671,5756,664,2575,764,9914,857,0004,157,0004,550,0004,559,0002,973,000
Interest Payable6,239,0416,826,3317,455,8838,252,2429,069,7389,844,89310,307,84510,643,41211,253,12211,907,47012,753,00013,589,00014,384,00014,765,00011,509,000
Interest Receivable17,962,84618,705,99120,292,51421,822,02022,959,76722,924,14317,633,96218,673,38419,782,88221,413,07722,053,00023,276,00024,951,00026,203,00020,668,000
Pre-Tax Profit15,727,54211,493,28419,532,20721,847,42121,369,27519,875,45914,906,49814,701,54715,194,01715,270,59814,157,00013,844,00015,117,00015,997,00012,132,000
Tax-3,300,316-1,685,212-9,355,656-6,224,201-3,794,652-3,608,947-2,777,752-1,145,331883,766-1,991,0312,566,000-976,000802,000-3,167,000-3,090,000
Profit After Tax12,427,2269,808,07210,176,55115,623,22017,574,62316,266,51212,128,74613,556,21616,077,78313,279,56716,723,00012,868,00015,919,00012,830,0009,042,000
Dividends Paid9,080,63115,139,0417,171,55019,560,67316,573,54214,598,04013,012,29911,211,83711,398,0007,281,0008,806,00010,176,0009,640,000
Retained Profit12,427,2269,808,0721,095,920484,17910,403,073-3,294,161-4,444,796-1,041,8243,065,4842,067,7305,325,0005,587,0007,113,0002,654,000-598,000
Employee Costs
Number Of Employees106100124141127125130145138230194169190171
EBITDA*4,003,737-386,3206,695,6588,279,3207,481,6156,798,5807,584,0046,676,5136,669,3225,773,0494,863,0004,162,0004,557,0004,586,0003,005,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets561381,8154,1846,55510,17815,11620,18127,00018,00022,00029,00054,000
Intangible Assets
Investments & Other69,090,45865,124,38361,385,97764,183,57764,183,57764,183,57764,183,57764,183,57764,183,57764,183,57764,184,00064,184,00064,184,00064,184,00064,184,000
Debtors (Due After 1 year)87,305,789108,452,279128,317,879136,773,536146,204,527158,381,098168,600,272185,358,535199,328,057214,956,413217,787,000230,527,000241,789,000249,915,000257,169,000
Total Fixed Assets156,396,247173,576,662189,703,912200,957,251210,389,919222,568,859232,790,404249,552,290263,526,750279,160,171281,998,000294,729,000305,995,000314,128,000321,407,000
Stock & work in progress1,103,0001,522,000953,0002,261,0001,222,000
Trade Debtors10,544,7497,278,8683,136,532679,30017,041,38815,151,47615,358,83916,151,78116,952,05615,874,18627,546,00024,484,00022,820,00017,424,00016,025,000
Group Debtors1,036,357976,866920,790962,754962,754962,754962,754962,754
Misc Debtors16,035,35019,092,53016,869,30920,375,39817,929,01914,836,71615,365,51912,727,62213,225,57012,357,66268,0001,207,000138,0005,043,0001,828,000
Cash52,934,16427,287,33921,362,52616,405,37920,847,89321,977,18023,722,99424,970,19023,553,11720,948,4658,551,0002,615,0002,657,00013,908,00012,632,000
misc current assets10,952,00013,525,00013,667,000
total current assets80,550,62054,635,60342,289,15738,422,83156,781,05452,928,12655,410,10654,812,34753,730,74349,180,31348,220,00043,353,00040,235,00038,636,00031,707,000
total assets236,946,867228,212,265231,993,069239,380,082267,170,973275,496,985288,200,510304,364,637317,257,493328,340,484330,218,000338,082,000346,230,000352,764,000353,114,000
Bank overdraft8,258,7549,620,893
Bank loan71,434,79884,719,56112,711,61611,561,37510,172,81311,778,6287,657,4645,184,988
Trade Creditors 3,099,5422,967,0402,384,1261,749,6781,929,827678,7133,818,6004,276,1806,988,3061,778,8776,266,0002,843,000431,0001,695,000697,000
Group/Directors Accounts6,047,9583,478,6411,430,4941,330,2031,228,7311,153,8052,027,8531,936,8421,915,3221,871,603963,000963,000963,000963,000971,000
other short term finances10,491,00010,944,00011,133,00014,047,00011,945,000
hp & lease commitments
other current liabilities36,408,69720,010,87717,180,34517,011,23033,890,81237,678,13833,259,45636,525,01835,214,39236,846,10934,048,00033,910,00040,181,00037,207,00034,521,000
total current liabilities116,990,995111,176,11933,706,58131,652,48647,222,18351,289,28446,763,37347,923,02852,376,77450,117,48251,768,00048,660,00052,708,00053,912,00048,134,000
loans17,274,52819,758,390111,483,607129,322,907143,913,693160,945,196178,984,613194,427,161194,460,549213,413,716176,819,000186,682,000196,961,000206,272,000218,595,000
hp & lease commitments
Accruals and Deferred Income2,765,8623,551,0334,454,4595,432,7566,512,0647,715,0477,656,1867,060,4576,200,2935,813,2755,219,0004,717,0004,215,0003,641,0003,262,000
other liabilities5,0005,000
provisions16,440,66123,455,58426,193,94722,148,08521,195,78922,550,88423,833,28925,464,72828,647,34633,964,88835,598,00042,534,00042,439,00046,150,00042,983,000
total long term liabilities36,481,05146,765,007142,132,013156,903,748171,621,546191,211,127210,474,088226,952,346229,308,188253,191,879217,636,000233,933,000243,620,000256,063,000264,845,000
total liabilities153,472,046157,941,126175,838,594188,556,234218,843,729242,500,411257,237,461274,875,374281,684,962303,309,361269,404,000282,593,000296,328,000309,975,000312,979,000
net assets83,474,82170,271,13956,154,47550,823,84848,327,24432,996,57430,963,04929,489,26335,572,53125,031,12360,814,00055,489,00049,902,00042,789,00040,135,000
total shareholders funds83,474,82170,271,13956,154,47550,823,84848,327,24432,996,57430,963,04929,489,26335,572,53125,031,12360,814,00055,489,00049,902,00042,789,00040,135,000
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit4,003,737-386,3766,695,5768,277,6437,479,2466,796,2097,580,3816,671,5756,664,2575,764,9914,857,0004,157,0004,550,0004,559,0002,973,000
Depreciation56821,6772,3692,3713,6234,9385,0658,0586,0005,0007,00027,00032,000
Amortisation
Tax-3,300,316-1,685,212-9,355,656-6,224,201-3,794,652-3,608,947-2,777,752-1,145,331883,766-1,991,0312,566,000-976,000802,000-3,167,000-3,090,000
Stock-1,103,000-419,000569,000-1,308,0001,039,0001,222,000
Debtors-20,878,298-13,443,967-9,546,478-23,346,700-7,194,356-10,955,340-14,913,308-14,304,991-13,682,578-2,212,739-10,817,000-8,529,000-7,635,000-2,640,000275,022,000
Creditors132,502582,914634,448-180,1491,251,114-3,139,887-457,580-2,712,1265,209,429-4,487,1233,423,0002,412,000-1,264,000998,000697,000
Accruals and Deferred Income15,612,6491,927,106-809,182-17,958,890-4,990,3094,477,543-2,669,8332,170,790-1,244,6993,392,384640,000-5,769,0003,548,0003,065,00037,783,000
Deferred Taxes & Provisions-7,014,923-2,738,3634,045,862952,296-1,355,095-1,282,405-1,631,439-3,182,618-5,317,542-1,633,112-6,936,00095,000-3,711,0003,167,00042,983,000
Cash flow from operations30,311,94711,144,09210,757,6088,215,0765,787,02914,200,22414,960,70816,112,21919,882,8544,369,90615,792,0007,884,00012,875,00010,250,000-194,866,000
Investing Activities
capital expenditure-1,239-15,000-1,000-2,000-86,000
Change in Investments3,966,0753,738,406-2,797,600-42364,184,000
cash flow from investments-3,966,075-3,738,4062,797,600-816-15,000-1,000-2,000-64,270,000
Financing Activities
Bank loans-13,284,76372,007,9451,150,2411,388,562-1,605,8154,121,1642,472,4765,184,988
Group/Directors Accounts2,569,3172,048,147100,291101,47274,926-874,04891,01121,52043,719908,603-8,000971,000
Other Short Term Loans -10,491,000-453,000-189,000-2,914,0002,102,00011,945,000
Long term loans-2,483,862-91,725,217-17,839,300-14,590,786-17,031,503-18,039,417-15,442,548-33,388-18,953,16736,594,716-9,863,000-10,279,000-9,311,000-12,323,000218,595,000
Hire Purchase and Lease Commitments
other long term liabilities-5,0005,000-5,0005,000
share issue776,4564,308,5924,234,7072,012,4254,927,5975,327,6865,918,582-5,041,4447,475,924-37,850,60740,733,000
interest11,723,80511,879,66012,836,63113,569,77813,890,02913,079,2507,326,1178,029,9728,529,7609,505,6079,300,0009,687,00010,567,00011,438,0009,159,000
cash flow from financing-699,047-1,480,873482,5702,481,451255,2343,614,635365,6388,161,648-2,903,764-1,332,681-1,016,000-786,000-1,653,0001,204,000281,408,000
cash and cash equivalents
cash25,646,8255,924,8134,957,147-4,442,514-1,129,287-1,745,814-1,247,1961,417,0732,604,65212,397,4655,936,000-42,000-11,251,0001,276,00012,632,000
overdraft-8,258,754-1,362,1399,620,893
change in cash25,646,8255,924,8134,957,147-4,442,514-1,129,287-1,745,814-1,247,1969,675,8273,966,7912,776,5725,936,000-42,000-11,251,0001,276,00012,632,000

consort healthcare (edinburgh royal infirmary) limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for consort healthcare (edinburgh royal infirmary) limited. Get real-time insights into consort healthcare (edinburgh royal infirmary) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Consort Healthcare (edinburgh Royal Infirmary) Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for consort healthcare (edinburgh royal infirmary) limited by selecting its closest rivals, whether from the CONSTRUCTION sector, other large companies, companies in EH1 area or any other competitors across 12 key performance metrics.

consort healthcare (edinburgh royal infirmary) limited Ownership

CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED group structure

Consort Healthcare (Edinburgh Royal Infirmary) Limited has no subsidiary companies.

Ultimate parent company

1 parent

CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED

SC187449

CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED Shareholders

project & export finance (nominees) limited 100%

consort healthcare (edinburgh royal infirmary) limited directors

Consort Healthcare (Edinburgh Royal Infirmary) Limited currently has 4 directors. The longest serving directors include Mr John Cavill (Oct 2009) and Mr Glenn Pearce (Mar 2021).

officercountryagestartendrole
Mr John CavillUnited Kingdom52 years Oct 2009- Director
Mr Glenn PearceUnited Kingdom52 years Mar 2021- Director
Mr Carl DixUnited Kingdom59 years Jan 2024- Director
Ms Francesca KavanaghUnited Kingdom39 years Mar 2025- Director

P&L

December 2023

turnover

23.5m

+13%

operating profit

4m

-1136%

gross margin

13.4%

-35.04%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

83.5m

+0.19%

total assets

236.9m

+0.04%

cash

52.9m

+0.94%

net assets

Total assets minus all liabilities

consort healthcare (edinburgh royal infirmary) limited company details

company number

SC187449

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

41201 - Construction of commercial buildings

43999 - Specialised construction activities (other than scaffold erection) n.e.c.

incorporation date

July 1998

age

27

incorporated

UK

accounts

Full Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

PRICEWATERHOUSECOOPERS LLP

address

c/o infrastructure managers limi, 2nd floor drum suite, saltire co, edinburgh, EH1 2EN

Bank

THE ROYAL BANK OF SCOTLAND PLC, THE ROYAL BANK OF SCOTLAND PLC

Legal Advisor

ADDLESHAW GODDARD

consort healthcare (edinburgh royal infirmary) limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 35 charges/mortgages relating to consort healthcare (edinburgh royal infirmary) limited. Currently there are 25 open charges and 10 have been satisfied in the past.

consort healthcare (edinburgh royal infirmary) limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CONSORT HEALTHCARE (EDINBURGH ROYAL INFIRMARY) LIMITED. This can take several minutes, an email will notify you when this has completed.

consort healthcare (edinburgh royal infirmary) limited Companies House Filings - See Documents

datedescriptionview/download